HeartFlow, Inc. (HTFL)

NMS – Real Time Price. Currency in USD

29.42

+0.03 (0.10%)

At close: May 12, 2026, 4:00 PM EDT

29.02

-0.40 (-1.36%)

Pre-market: May 13, 2026, 7:09 AM EDT

23.04.2026

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

SAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the first quarter of 2026 after market close on Thursday, May 14, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on May 14, 2026.

13.04.2026

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform Heartflow asserts that Cleerly infringed foundational patented technology central to the Heartflow Platform

25.03.2026

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

HeartFlow's chief medical officer exercised 67,017 options and sold 64,533 Common Stock shares on March 19, 2026, generating proceeds of about $1.66 million at an average price around $25.69 per share. The sale represented 22.36% of Campbell's direct common stock holdings at the time of the transaction.

22.03.2026

Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?

Capricorn Investment Group LLC bought 1,661,601 HeartFlow shares; estimated transaction value $48.18 million based on quarterly average price. The quarter-end position value increased by $48.18 million, reflecting the new share purchase.

19.03.2026

HeartFlow: Getting Into The Flow

HeartFlow delivered 40% sales growth in 2025, with revenue surpassing $176 million and strong Q4 momentum. 2026 guidance targets 25% revenue growth to $218–222 million, with gross margins rising to 80–81% and further mid-term upside to 85%. HearthFlow's AI-driven CAD diagnostic platform is gaining adoption, supported by FDA-cleared next-generation algorithms and a proprietary CT image database.

18.03.2026

HeartFlow, Inc. (HTFL) Q4 2025 Earnings Call Transcript

16.03.2026

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Three presentations at ACC reinforce Heartflow's AI-powered technology predicts MACE, drives superior lipid outcomes and results in cost-effective care First patient enrolled in p ioneering N AVIGATE - PCI Registry assessing impact of Heartflow PCI Navigator on clinical strategy, efficiency and physician confidence across 5,000 patients MOUNTAIN VIEW, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced new clinical evidence and a landmark registry launch that together advance the company's vision of transforming CAD management across every stage of the patient journey.

Videos

No Data

There is no data to display

Press releases

13.04.2026

Heartflow Files Patent Infringement Lawsuit Against Cleerly

16.03.2026

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

18.02.2026

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

MOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Morgan Stanley Technology, Media & Telecom Conference. The presentation will take place in San Francisco, CA, on Tuesday, March 3, 2026, at 10:45 a.m. PT / 1:45 p.m. ET.

06.01.2026

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis is now covered by Aetna across all lines of business, including Commercial, Medicare Advantage, and Aetna Better Health Medicaid plans.

HeartFlow, Inc. (HTFL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

HeartFlow, Inc. (HTFL)

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Heartflow Files Patent Infringement Lawsuit Against Cleerly

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?

HeartFlow: Getting Into The Flow

HeartFlow, Inc. (HTFL) Q4 2025 Earnings Call Transcript

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Videos

No Data

Press releases

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Heartflow Files Patent Infringement Lawsuit Against Cleerly

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?

HeartFlow: Getting Into The Flow

HeartFlow, Inc. (HTFL) Q4 2025 Earnings Call Transcript

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Videos

No Data

Press releases

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Search stocks

HeartFlow, Inc. (HTFL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

HeartFlow, Inc. (HTFL)

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Heartflow Files Patent Infringement Lawsuit Against Cleerly

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?

HeartFlow: Getting Into The Flow

HeartFlow, Inc. (HTFL) Q4 2025 Earnings Call Transcript

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Videos

No Data

Press releases

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.

Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026

Heartflow Files Patent Infringement Lawsuit Against Cleerly

What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale

Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares?

HeartFlow: Getting Into The Flow

HeartFlow, Inc. (HTFL) Q4 2025 Earnings Call Transcript

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Videos

No Data

Press releases

Heartflow Files Patent Infringement Lawsuit Against Cleerly

Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning

Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.